Net delta positioning extremes

Which liquid chains had the strongest positive and negative delta-weighted positioning on Oct 8, 2026?

Aggregate option-holder delta divided by 100 shares times total open interest. The 25 most positive observations appear first, followed by the 25 most negative. Data through Oct 8, 2026 close. Descriptive only, not a recommendation.

At a glance

50 tickers qualified. First five: XP (0.670), ETHA (0.637), INO (0.577), AVTR (0.544), PBR.A (0.540).

Net delta positioning extremes as of Oct 8, 2026 close
#	Ticker	Close	Open interest	Normalized net delta
1	XP	30.21	1,001,724	0.670
2	ETHA	55.70	435,234	0.637
3	INO	1.09	113,728	0.577
4	AVTR	15.39	126,292	0.544
5	PBR.A	22.14	217,196	0.540
6	CRON	3.22	105,307	0.533
7	CHGG	0.74	123,448	0.531
8	CORN	18.96	131,984	0.513
9	HE	8.82	115,422	0.498
10	QSI	1.22	107,261	0.485
11	REI	1.35	120,842	0.476
12	PACB	2.30	190,749	0.469
13	UPXI	1.08	159,091	0.459
14	PGEN	7.60	113,005	0.458
15	APA	45.47	195,885	0.453
16	CODI	10.92	259,538	0.443
17	CAN	0.29	150,790	0.429
18	DHT	24.93	173,780	0.416
19	BNO	63.64	308,310	0.408
20	HLF	12.82	139,156	0.407
21	IBRX	9.91	680,790	0.406
22	BTG	5.12	588,034	0.398
23	SG	9.57	275,418	0.397
24	OSCR	33.10	452,298	0.393
25	RBRK	120.89	100,470	0.392
26	ARDX	3.27	208,970	-0.382
27	UAA	4.88	507,883	-0.300
28	IHI	51.10	234,057	-0.277
29	ABR	3.09	164,738	-0.252
30	MMED	19.80	168,806	-0.238
31	KKR	89.56	277,113	-0.229
32	FEZ	65.57	154,285	-0.202
33	XEL	73.36	206,332	-0.197
34	CG	38.39	109,954	-0.195
35	NLY	18.27	195,303	-0.189
36	AGNC	8.68	791,697	-0.188
37	INFY	10.70	209,524	-0.185
38	BX	112.70	489,455	-0.178
39	OWL	9.27	838,663	-0.166
40	NVS	143.11	120,673	-0.164
41	TCOM	37.96	105,729	-0.161
42	ASHR	32.14	568,653	-0.161
43	HYG	77.14	10,370,623	-0.150
44	XRT	83.91	150,141	-0.137
45	EFA	102.70	1,369,279	-0.135
46	GIS	32.59	255,966	-0.134
47	KRE	69.59	2,579,109	-0.125
48	GT	4.75	176,097	-0.124
49	IYR	94.67	148,322	-0.123
50	LQD	102.47	2,900,808	-0.122

Screens describe what the data shows after the close. They are not trade recommendations; see the disclaimer and the methodology.